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ABSTRACT The origins of clot rheological behavior associated with network morphology and factor XIIIa-induced cross-
linking were studied in fibrin clots. Network morphology was manipulated by varying the concentrations of fibrinogen,
thrombin, and calcium ion, and cross-linking was controlled by a synthetic, active-center inhibitor of FXIIIa. Quantitative
measurements of network features (fiber lengths, fiber diameters, and fiber and branching densities) were made by analyzing
computerized three-dimensional models constructed from stereo pairs of scanning electron micrographs. Large fiber
diameters and lengths were established only when branching was minimal, and increases in fiber length were generally
associated with increases in fiber diameter. Junctions at which three fibers joined were the dominant branchpoint type.
Viscoelastic properties of the clots were measured with a rheometer and were correlated with structural features of the
networks. At constant fibrinogen but varying thrombin and calcium concentrations, maximal rigidities were established in
samples (both cross-linked and noncross-linked) which displayed a balance between large fiber sizes and great branching.
Clot rigidity was also enhanced by increasing fiber and branchpoint densities at greater fibrinogen concentrations. Network
morphology is only minimally altered by the FXIIIa-catalyzed cross-linking reaction, which seems to augment clot rigidity most
likely by the stiffening of existing fibers.
INTRODUCTION
Fibrinogen is made up of two identical halves, each con-
taining three different peptide chains (A, B, and ) that
are held together by a network of disulfide bonds. By
electron microscopy the molecule appears as a trinodular
structure, having a central domain, consisting of the amino
termini of all six chains, and two end domains, whose
proximal and distal regions are comprised of the carboxy-
terminal ends of the B chains and  chains, respectively
(Weisel et al., 1985). The carboxy-terminal portions of the
A chain depart from the end domains and fold into a
conformation that stretches back toward the central domain
(Erickson and Fowler, 1983; Weisel et al., 1985; Veklich et
al., 1993; Gorkun et al., 1994).
The conversion of fibrinogen into a network of fibrin
fibers occurs through a series of steps. Under physiological
conditions, thrombin catalyzes the hydrolytic removal of
fibrinopeptides A and B from fibrinogen, converting the
molecule to fibrin and revealing binding sites at its central
domain that interact with complementary sites at the end
domains of other fibrin molecules. These noncovalent in-
teractions cause fibrin monomers to assemble in a half-
staggered manner into two-stranded protofibrils. Upon
growing to sufficient length, the protofibrils aggregate lat-
erally to form fibers that branch into a three-dimensional
network.
The network is further stabilized in the presence of factor
XIIIa through the formation of N-(-glutamyl)lysine
isopeptide bonds (which are called cross-links or ligations)
(Lorand et al., 1968; Matacic and Loewy, 1968; Pisano et
al., 1968). Ligations between Lys406 and Glu398 of the
-chains of adjacent fibrin molecules result in the formation
of -dimers (Chen and Doolittle, 1969, 1971; McKee et al.,
1970; Doolittle et al., 1971) and -multimers (Murthy and
Lorand, 1990; Shainoff et al., 1991; Siebenlist and Moses-
son, 1992); ligations between the multiple cross-linking
sites on the -chains produce -polymers (McKee et al.,
1970; Schwartz et al., 1971; Sobel et al., 1988; Gron et al.,
1992). Factor XIIIa-induced hybrid -ligations have also
been observed (Mosesson et al., 1989; Murthy and Lorand,
1990; Shainoff et al., 1991; Gron et al., 1993).
Covalent cross-linking within fibrin networks produces
dramatic effects on clot rheological properties. Ligated clots
exhibit mechanical stiffnesses up to five times greater than
their unligated counterparts (Ferry et al., 1951; Roberts et
al., 1973; Gerth et al., 1974; Mockros et al., 1974; Glover et
al., 1975; Shen et al., 1975; Shen and Lorand, 1983) and do
not display the stress-induced structural rearrangements
seen in unligated clots by creep and by permanent defor-
mation after creep recovery (Nelb et al., 1976, 1981; Jan-
mey et al., 1983). The mechanism by which cross-linking
augments clot stiffness remains undetermined. The en-
hancement of rigidity in ligated clots has been attributed
mainly to the development of -polymers, whereas
-dimerization is thought to have a smaller (Gladner and
Nossal, 1983) or negligible effect (Shen et al., 1974, 1975)
on network rigidity.
Early efforts were made (Nelb et al., 1981) to describe the
origins of clot rigidity using a model of randomly interpen-
etrating stiff rods (Doi and Kuzuu, 1980). The network
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theory for rubber elasticity was also used to estimate the
“cross-linking densities” of clots from their stiffnesses
(Ferry and Morrison, 1947; Kaibara and Fukada, 1970;
Glover et al., 1975, 1977). Dissimilarities between features
of these models and fibrin networks, however, limited their
success in identifying the contributions made by the various
molecular interactions to clot mechanical behavior.
Clot stiffness is thought to be strongly dependent on
fibrin fiber thickness and flexural stiffness, branchpoint
density, and fibrin concentration (Roberts et al., 1974; Gerth
et al., 1974; Glover et al., 1975; Shen et al., 1975; Nelb et
al., 1976). Quantitative correlations between the structural
features of clots and their rheology have not been made,
partly due to the difficulty of quantitatively analyzing the
morphology of the often complex fibrin networks. Qualita-
tive descriptions of network architecture by microscopy
under various clotting conditions have been well-docu-
mented (Muller et al., 1984; Blomback et al., 1990; Weisel
and Nagaswami, 1992; Weisel et al., 1993; Gorkun et al.,
1994), and fiber sizes have been estimated using fiber mass
to length ratios calculated from light-scattering and perme-
ation techniques (Carr et al., 1977, 1987; Carr and Hermans,
1978; Blomback et al., 1984, 1990; Shah et al., 1985).
Direct measurements of clot structural features, however,
have been limited.
In the present investigation, extensive quantitative anal-
ysis of network features (fiber lengths, diameters, branch-
point densities, and fiber densities) was made using a re-
cently developed method of constructing computerized
three-dimensional wire frame models of fibrin networks
from stereo electron micrographs (Baradet et al., 1995).
Stereo viewing of the networks was particularly useful for
measuring fiber lengths in three dimensions and distinguish-
ing branchpoints from fibers that merely crossed each other
at different depths. Network structure in clots of purified
fibrin was manipulated by varying fibrinogen, thrombin,
and calcium ion concentrations, and cross-link formation
was controlled through the use of a highly specific, active-
center-directed synthetic inhibitor of FXIIIa, 1,3,4,5-tetra-
methyl-2[(2-oxopropyl)thio]imidazolium chloride (Freund
et al., 1994). By measuring clot viscoelastic properties with
a cone and plate rheometer and analyzing cross-linking with
SDS-PAGE, a correlation was determined between the
structural features of the ligated and nonligated clots and
their rheology.
MATERIALS AND METHODS
Human fibrinogen (plasminogen free; American Diagnostica, Greenwich,
CT) was dissolved in water, dialyzed against 4 l of 50 mM Tris-HCl, pH
7.5, 150 mM NaCl, 1 mM EDTA at 4°C, and stored at 80°C. Protein
concentration was determined by absorbance at 280 nm (E1cm
1%  15.1;
Mihalyi, 1968). The commercial fibrinogen was contaminated by small
amounts of FXIII, as judged by the detection of bands of n and –
cross-linked chains in reducing SDS-PAGE after the fibrinogen (6 M)
had been clotted with human -thrombin (1 NIHU/ml) and CaCl2 (5 mM)
for 90 min at 37°C. Human -thrombin (a gift from Dr. J. W. Fenton II,
New York State Department of Health, Albany, NY) was diluted to 500
NIHU/ml in 50 mM Tris-HCl, 150 mM NaCl, pH 7.5 and stored at80°C.
The synthetic inhibitor of factor XIIIa, 1,3,4,5-tetramethyl-2[(2-oxopropy-
l)thio]imidazolium chloride (L682777, generously provided by Dr. An-
drew Stern, Merck, Sharp and Dohme Research Laboratories, West Point,
PA), was dissolved in water and stored at 20°C at a concentration of
100 mM.
Scanning electron microscopy of fibrin clots
Clots were prepared for scanning electron microscopy (SEM) from mix-
tures that typically contained 0.5–6 mg/ml fibrinogen, 0–5 NIHU/ml
thrombin, 0–20 mM CaCl2, 0 or 1 mM inhibitor L682777, 50 mM
Tris-HCl (pH 7.5), and sufficient amounts of NaCl (from a stock of 150
mM) to maintain the final ionic strength at 0.15. These reaction compo-
nents were thoroughly premixed with a pipette tip in 1.5-ml Eppendorf
tubes in 120 l volumes, with thrombin added as a last step to initiate
clotting. The mixtures were quickly transferred in volumes of 50 l from
the tube to plexiglass microdialysis cells perforated for solvent perfusion.
Clotting proceeded in a moist atmosphere at room temperature (20–22°C)
for 2 h. Samples were then fixed, dehydrated, critical point-dried, and
sputter-coated according to the methods of Langer et al. (1988). The
specimens were washed 3 times by permeation with 50 mM sodium
cacodylate-HCl buffer (pH 7.4) to remove excess salt and fixed overnight
in 2% glutaraldehyde. Clots were then washed 4 times in distilled water,
dehydrated in a graded series of increasing ethanol concentrations (30–
100%) over 3.5 h, and critical point-dried with CO2 in a DCP-1 critical
point drying apparatus (Denton Vacuum Co., Cherry Hill, NJ). The spec-
imens were mounted, sputter-coated with gold-palladium in an SEM coat-
ing unit E5100 (Polaron Instruments, Inc., West Sussex, England) at 2.2 kV
and 20 mA for 1.5 min, and examined in a Philips XL20 scanning electron
microscope (Philips Electronics Co., Mahwah, NJ). Duplicates of each clot
were made, and several fields on each clot were examined before choosing
fields that were characteristic of the entire clot. Digitized electron micro-
graphs were taken at magnifications (between 4000 and 25,000) that
included a relatively high number of branchpoints (300) and fibers
(500). Stereo pairs were generated by taking pictures in 7.5° increments
between 7.5° and 45° by using a tilting, eucentric stage on the microscope.
Computerized three-dimensional reconstructions
and quantitative characterization of
fibrin networks
Methods of fibrin network analysis were modified from those of Baradet et
al. (1995). Digitized scanning electron micrographs were analyzed by
custom image analysis software routines written in C by Lou Fodor
(Department of Biology, University of Pennsylvania). The images were
viewed in stereo with a Crystal Eyes StereoGraphics optical stereo viewer
(StereoGraphics Corporation, San Rafael, CA) on a Silicon Graphics
Indigo 2 workstation (Silicon Graphics, Inc., Mountain View, CA). Using
a series of seven stereo micrograph pairs, the analysis software allowed the
three-dimensional specimen images to be viewed and rotated 45° about
a vertical (x) axis. Fiber branchpoints (points at which three or more fibers
joined together) were marked directly on the image with a cursor that could
be moved in the x-, y-, and z-directions (Fig. 1). Series of several straight
links representing fiber segments between the branchpoints were con-
structed and could be edited to follow the images of the actual fibers in
three dimensions.
The complete length of a fiber was defined as the distance measured
along the fiber between its terminal branchpoints. Fiber lengths were thus
obtained from the reconstructed networks by summing the lengths of the
links constructed between branchpoints. In all of the SEM images analyzed
in this study, a large number of fibers extended beyond the boundaries of
the image before branching or joining with other fibers; therefore, their
complete lengths could not be measured. Instead, the lengths of the
portions of fibers that could be observed in the image were recorded and
considered statistically “censored.” These incomplete fiber lengths were
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included in the analysis of the data, for excluding them would bias the data
toward the shorter lengths, particularly in images that included fibers with
lengths longer than the dimensions of the image. By using Kaplan-Meier
product limit estimates for treating censored data (Kaplan and Meier,
1958), the data were found to fit a gamma distribution from which mean
and standard deviations of the fiber lengths were estimated.
Clot fiber diameters were measured directly from high-definition mi-
crographs obtained from the Phillips SEM using public domain National
Institutes of Health Image program 1.61 (US National Institutes of Health,
Bethesda, MD). Fiber and branchpoint densities were calculated by divid-
ing the total number of fibers and branchpoints measured in the fibrin
network models by the volumes taken up by the reconstructions. The
presence of incomplete fibers was taken into account in the calculation of
fiber densities, assuming that, on average, half the actual (complete)
lengths of the incomplete fibers was included inside the network volumes.
Estimates of the network volumes were calculated using Matlab software
Version 5.0 (The Math Works, Inc., Natick, MA).
Measurement of clot rigidity
A VOR Rheometer (Bohlin Rheologi, Cranbury, NJ) was used to examine
the viscoelastic properties of clots having compositions identical to those
analyzed by SEM and gel electrophoresis. Reaction components were
premixed in a 1.5-ml Eppendorf centrifuge tube with enough buffer (50
mM Tris-HCl, 100–150 mMNaCl, pH 7.5) to bring the total volume to 330
l and maintain the final ionic strength at 0.15. After the addition of
thrombin, the last step for initiating coagulation, the reaction components
were thoroughly mixed with a pipette tip, and 325 l of the clotting
mixture were quickly transferred from the tube to the stainless steel
rheometer cone and plate fixture (which had a 2.5° cone angle and 30 mm
diameter). Measurements were taken at 0.1 Hz under an imposed strain of
0.015. For measuring purposes, the rheometer was operated in an oscilla-
tory mode, with data collected over 10-s periods every 2 min. Between the
2-min intervals, the clot remained at rest. The storage modulus (G), a
measure of the elastic energy stored during the deformation imposed by
one oscillation of the rheometer, was calculated by Bohlin VOR Rheometer
Software Version 4.05 (Bohlin Reologi AB, Sweden) and used as a
measure of clot rigidity. The loss modulus (G), which reflects the energy
dissipated by the clot during deformation, was also recorded and used to
calculate the loss tangent (tan  G/G), the ratio of energy lost to energy
stored in a cyclic deformation. Coagulation proceeded at 21°C. To prevent
dehydration, heavy mineral oil (Walgreen Co., Deerfield, IL) was applied
to a ring surrounding the exposed surfaces of the clots at the beginning of
the experiments.
Measurement of clotting time
Reaction mixtures comprised of fibrinogen (3 mg/ml), thrombin (0.25, 0.5,
1 NIHU/ml) and FXIIIa inhibitor (L682777, 1 mM) were mixed at room
temperature (20–22°C) in borosilicate culture tubes (12  75 mm, Baxter
Healthcare Corp., McGaw Park, IL). Enough buffer (50 mM Tris-HCl,
100–150 mM NaCl, pH 7.5) was used to bring the volumes to 500 l and
maintain the final ionic strength at 0.15. After the addition of thrombin, the
last step for initiating coagulation, the reaction components were gently
swirled in the tube and tilted every 15 s until clot formation was visually
detected. The times at which the clots were formed were recorded.
Samples having the same compositions as those formed in the tubes
were analyzed by rheometry. The G values established by the clots at their
previously recorded times of appearance in the culture tubes were taken to
be the rigidities of the clots developed at their initial formation. The
average of these G values was 0.73 	 0.16 Pa. In subsequent rheometry
experiments, clotting time was defined as the time at which sample rigidity
reached 0.73 Pa.
Analysis of fibrin cross-linking by SDS-PAGE
Electrophoretic experiments to assess the cross-linking profiles of clots
were carried out on mixtures of compositions identical to those used for
rheological measurements and SEM analysis. Clots were formed at 21°C in
25 l reaction mixtures. The ligating reaction in the samples was stopped
by solubilization in 6 M urea, 40 mM dithiothreitol, and 2% SDS at 37°C
for 45–60 min. Gel electrophoresis (8% acrylamide) was performed by the
procedure of Laemmli (1970) in a Mini-Protean II Dual Slab Cell (BioRad,
Hercules, CA). Samples of 6 g protein per lane were analyzed, and a
broad-range molecular weight standard (BioRad) was used for reference.
Coomassie brilliant blue R (0.025% in 10% acetic acid and 20% methanol)
was used for staining. Photographs of the gels focus on the protein bands
with Mr values higher than 31,000. Relative intensities of Coomassie
blue-stained bands were measured in an LKB Ultroscan XL Laser Densi-
tometer (Bromma, Sweden) and quantitated by excising and weighing the
peak areas.
RESULTS
Clot architecture
The reference clotting mixture in this study was composed
of fibrinogen (3 mg/ml), thrombin (1 NIHU/ml) and FXIIIa
inhibitor (1 mM), Figure 2 shows the changes in clot archi-
tecture as fibrinogen (Fig. 2 A) and thrombin (Fig. 2 B)
concentrations were varied and as CaCl2 was included in the
mixture (Fig. 2 C). The latter also shows the architecture of
ligated clots formed by omitting the FXIIIa inhibitor and
adding CaCl2. Fig. 3 shows the quantitative results of anal-
yses of these clots by computerized three-dimensional mod-
eling. Fiber diameters decreased (from 72 to 46 nm) as the
fibrinogen concentration increased from 0.5 to 6 mg/ml,
decreased (108 to 44 nm) as the thrombin concentration
increased from 0.05 to 5 NIHU/ml, and increased (85 to 147
nm for unligated and 69 to 131 nm for ligated) as the CaCl2
concentration increased from 0.2 to 20 mM. Fiber lengths
were relatively insensitive to fibrinogen concentration
(range: 0.8–0.4 m), decreased (4.0–0.3 m) with in-
creased thrombin concentration, and increased (1.0 to 3.9
m for unligated and 1.1 to 4.8 m for ligated) as the Ca2

increased. Fiber and branchpoint densities were relatively
insensitive to fibrinogen concentration between 0.5 and 3
FIGURE 1 Depiction of the process for building three-dimensional net-
work reconstructions. (A) Digitized scanning electron micrographs of fibrin
networks were viewed in stereo (nonstereo image shown here). (B) Branch-
ing junctions and endpoints of the fibers were marked on the three-
dimensional image, and the x-y-z coordinates of these points were recorded
by the image analysis program. (C) Series of links representing fibers were
constructed between the marked branchpoints or fiber endpoints. The links
could be edited to follow the fibers in three dimensions.
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mg/ml, but both increased over threefold at 6 mg/ml. De-
spite these changes at the high fibrinogen concentration, the
lengths of the fibers remained relatively constant, indicating
that the increased branchpoint density at the high fibrinogen
concentration resulted from greater density of fiber struc-
tures and not from an increased incidence of branching
along the fibers. The similarity between the fiber densities
and diameters of samples formed from 0.5 and 3 mg/ml
fibrinogen may be explained by the possible greater shrink-
age of the clot volume at the lower concentration of the
protein during critical point drying. Fiber and branchpoint
densities increased manyfold with increased thrombin con-
centration, whereas they decreased manyfold with increased
CaCl2.
Figs. 2 C and 3 C also show comparisons between unli-
gated and ligated clots with variations in CaCl2 concentra-
tions and suggest no major differences in lengths, diameters,
or fiber and branchpoint densities between the two types of
clots. Large-sample tests, however, reveal that the differ-
ences in fiber lengths (ligated clot fibers were 11 to 22%
longer) and fiber diameters (ligated clot fibers were 11 to
19% smaller in diameter) were statistically significant, p 
FIGURE 2 Scanning electron micrographs of clots formed with varying mixtures. (A) Reaction mixtures were comprised of fibrinogen [0.5 (a), 3 (b),
or 6 (c) mg/ml], thrombin (1 NIHU/ml), and FXIIIa inhibitor (1 mM). (B) Reaction mixtures were comprised of fibrinogen (3 mg/ml), thrombin [0.05 (a),
1 (b), or 5 (c) NIHU/ml], and FXIIIa inhibitor (1 mM). (C) Reaction mixtures were comprised of fibrinogen (3 mg/ml), thrombin (1 NIHU/ml), CaCl2 [0
(a), 0.2 (b, e), 5 (c, f), or 20 (d, g) mM], and 1 mM (a–d) or 0 mM (e–g) FXIIIa inhibitor. Clots were incubated for 2 h at 20–22°C. Bar  0.5 m.
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0.0103 and p  0.000003, respectively. These results sug-
gest that the covalent bonds formed with the presence of
FXIIIa significantly tightens the lateral attachments be-
tween fibrin molecules within a fiber, but does not add or
subtract more fibrin monomers to each fiber. Tables 1 and
2 summarize the compositions and network characteristics
for all the clots developed in this investigation.
Clot rheology
Figs. 4–6 shows the physical properties of clots (using the
same mixtures as those formed for the SEM) as a function
of the fibrinogen, thrombin, and CaCl2 concentrations, re-
spectively. A clotting period of 2 h was found to be suffi-
cient to effect essentially full development of clot stiffness
with all variations of fibrinogen concentration (Fig. 4). Final
stiffnesses (G at 2 h) were proportional to the 1.67 power
of the starting fibrinogen (c) concentration, consistent with
the results of Ferry and Morrison (1947); Roberts et al.
(1974); Gerth et al. (1974); and Nelb et al. (1976), who
reported the concentration dependence of G for unligated
fibrin clots to vary between c1.5 and c1.57. Other investiga-
tors reported relationships of G  c2 (fibrin clots formed
with 0.05–0.8 mg/ml fibrinogen; Shen et al., 1975), G 
c2.1 (fibrin clots formed with 5–20 mg/ml fibrinogen;
Fukada and Kaibara, 1973); G  c1.7 (plasma clots, Fukada
and Kaibara, 1973), and G  c (platelet free plasma clots;
Glover et al., 1975). At 2 h, values of the loss modulus (G)
were 20–40 times smaller than those of G, as reflected
by the small values of the loss tangent (tan   G/G). The
loss moduli at 2 h were proportional to the 1.44 power of
fibrinogen concentration (G  c1.44). The value of tan  for
the sample containing no fibrinogen could not be accurately
determined, due to the limited sensitivity of the rheometer in
recording values of G and G at very small substrate
concentrations. As substrate concentrations were raised
from 0.5 to 6 mg/ml, values of tan  decreased slightly.
FIGURE 3 Effects of mixture constituents on the architecture of the fibrin networks shown in Fig. 2. (A) Effects of fibrinogen concentration on the
unligated fibrin networks shown in Fig. 2 A. (B) Effects of thrombin concentration on the unligated fibrin networks shown in Fig. 2 B. (C) Effects of calcium
concentration on the fibrin networks shown in Fig. 2 C. Clots were formed with 0 mM (solid symbols) or 1 mM (open symbols) FXIIIa inhibitor. Error
bars represent standard deviations of the data.
TABLE 1 Compositions of clots analyzed
Clot
Fibrinogen
(mg/ml)
Thrombin
(NIHU/ml)
CaCl2
(mM)
FXIIIa
inhibitor (mM)
A 0.5 1 0 1
B 3 1 0 1
C 6 1 0 1
D 3 0.05 0 1
E 3 5 0 1
F 3 1 0.2 1
G 3 1 5 1
H 3 1 20 1
I 3 1 0.2 0
J 3 1 5 0
K 3 1 20 0
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Clotting times gradually increased as fibrinogen concentra-
tions were raised.
A clotting period of 15 h was necessary to effect essen-
tially full development of clot stiffness for some of the
thrombin concentrations utilized (Fig. 5). With low throm-
bin concentrations (0.1 and 0.25 NIHU/ml) the rate of
stiffness development is slow but the final stiffness is rela-
tively high compared to those formed with more thrombin.
Clotting times decreased dramatically between 0 and 1
NIHU/ml and appeared to approach their minimum levels
above 1 NIHU/ml. Values of G at 2 (open circles) and 15 h
(open triangles) rose sharply between 0 and 0.25 NIHU/ml
and then decreased to lower plateauing values as thrombin
levels increased to 5 NIHU/ml. The G values observed at
2 h at low thrombin concentrations (below 0.1 NIHU/ml)
were small due to incomplete clot development. The rates of
stiffening at these low enzyme concentrations were so di-
minished that, at time periods even longer than 2 h, “final”
rigidities would still likely have been smaller than those of
clots formed at concentrations near 0.1 NIHU/ml. A maxi-
mum rigidity at 2 h occurred at a thrombin concentration
(0.25 NIHU/ml) that yielded a network with fiber lengths of
2 m, diameters of 83 nm, fiber densities of 9.3
m3, and branchpoint densities of 5 m3 (see Fig. 3
FIGURE 4 Clotting time and rheological
behavior of unligated clots formed with
varying concentrations of fibrinogen. Clots
were formed at 21°C from solutions of fi-
brinogen (0, 0.5, 1.5, 3, 4.5, 6 mg/ml),
thrombin (1 NIHU/ml), and FXIIIa inhibitor
(1 mM). Clotting times and values of G, G,
and tan  were averaged from two sets of
data; error bars represent ranges of the data.
TABLE 2 Summary of quantitative measurements of fibrin network features
Clot*
Number
of Fiber
Lengths
Measured
Estimated
Fiber Length
(m)
(Mean 	 SD)
Range of
Fiber
Lengths
(m)
Number
of Fiber
Diameters
Measured
Fiber
Diameter
(nm)
(Mean 	 SD)
Range of
Fiber
Diameters
(nm)
Fiber Density
(fibers, m3)
Branchpoint
Density
(branchpts, m3)
A 1104 0.7 	 0.4 0.1–3.2 523 72	 23 28–201 42 26
B 985 0.8 	 0.5 0.1–6.4 564 61	 22 17–196 35 21
C 909 0.4 	 0.2 0.1–2.0 572 46	 21 16–183 125 80
D 516 4.0 	 3.1 0.3–15 563 108	 40 26–325 1.2 0.8
E 977 0.3 	 0.2 0.1–1.3 581 44	 15 20–130 215 137
F 760 1.0 	 0.7 0.1–5.2 580 85	 32 28–285 17 11
G 750 2.1 	 1.5 0.2–7.9 597 104	 37 33–313 3.8 2.6
H 620 3.9 	 2.8 0.4–16 577 147	 59 41–391 0.5 0.4
I 924 1.1 	 0.8 0.1–5.8 573 69	 24 27–226 13 7.7
J 521 2.4 	 1.8 0.2–8.3 573 93	 36 27–281 4.8 3.2
K 635 4.8 	 3.5 0.4–19 557 131	 49 41–352 0.6 0.4
*Refer to Table 1 for clot compositions.
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B). These fiber sizes and fiber and branchpoint densities
were “intermediate” in magnitude, relative to the entire
range of fiber sizes and fiber and branchpoint densities
measured in this investigation (see Table 2). The peaking
behavior observed in G at 2 and 15 h was also reproduced
in G at 2 and 15 h, although values of the loss moduli were
10–45 times smaller than those of the storage moduli. No
clotting was observed in the absence of thrombin and the
limited sensitivity of the rheometer prevented an accurate
determination of the loss tangent for samples formed with 0
NIHU/ml thrombin. The tan , however, dropped sharply
between 0.1 and 0.5 NIHU/ml thrombin and decreased to
lower plateauing values between 0.5 and 5 NIHU/ml. A
similar decrease in tan  was observed by Kaibara and
Fukada (1971) between 0.2 and 1.7 NIHU/ml thrombin.
Two hours were sufficient for essentially developing the
full clot stiffness for all variations of CaCl2 concentrations
for unligated clots, but not sufficient for many CaCl2 con-
centrations for ligated clots (Fig. 6). The 2-h G values of
clots formed with inhibitor (open circles) were two to four
times smaller than those formed without inhibitor (solid
circles). The G values of clots measured at 2 h increased as
calcium rose from 0 to 1.5 mM and then decreased at
concentrations above 1.5 mM. The changes in clot stiffness
were not due to differences in ionic strength, for the NaCl
concentrations in the buffer solution were adjusted to main-
tain a constant ionic strength in all the samples. Consistent
with the results of the experiment in which thrombin con-
centrations were varied, the maximum rigidities for samples
formed both in the presence and absence of inhibitor oc-
curred at a calcium ion concentration (1.5 mM, the normal
physiological level in plasma) that produced a network
structure with fiber lengths (1.3 m, unligated; 1.4 m,
ligated), diameters (90 nm, unligated; 75 nm, ligated),
densities (8.4 m3, unligated; 9.1 m3, ligated), and
degrees of branching (5.1 m3, unligated and ligated)
that were “intermediate” (see Fig. 3 C). The loss moduli of
the samples formed without inhibitor were two to four times
smaller than those formed with inhibitor. At 2 h, the values
of G were 60–230 times smaller than G for the ligated
clots and 10–20 times smaller for the unligated clots. The
loss tangent for both clot types steadily increased as calcium
concentrations were raised from 0 to 5 mM and increased at
much slower rates from 5 to 20 mM CaCl2. Clotting times
decreased sharply as calcium concentrations were raised
from 0 to 2.5 mM and then plateaued to constant minimums
between 5 and 20 mM. The rates of clotting for both the
ligated and unligated samples were similar at all calcium ion
concentrations.
Cross-link analysis
Fig. 7 shows the cross-link analysis by SDS-PAGE for clots
having compositions equal to those formed for the SEM and
clot rheology. It reveals that in the presence of 1 mM
inhibitor no ligating of the fibrin - or -chains occurred
within the range of calcium concentrations used (Fig. 7 A).
In the absence of FXIIIa inhibitor, full depletion of 
monomers and formation of -dimers occurred by 0.2 mM
CaCl2 (Fig. 7 B). A progressive depletion of the -mono-
mers occurred as CaCl2 was raised from 0.2 to 20 mM,
resulting in the formation of bands that have customarily
been identified as n-polymers and ligated -hybrids. Fig.
FIGURE 5 Clotting time and rheological be-
havior of unligated clots formed with varying
concentrations of thrombin. Clots were formed
at 21°C from solutions of fibrinogen (3 mg/ml),
thrombin (0, 0.1, 0.25, 0.5, 1, 5 NIHU/ml), and
FXIIIa inhibitor (1 mM). Clotting times and
values of G, G, and tan  at 2 h (open circles)
and 15 h (open triangles) were averaged from
two sets of data; error bars represent ranges of
the data.
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6 shows that clots formed without inhibitor continued to
stiffen past 2 h, particularly at intermediate calcium con-
centrations (0.2–5 mM), at which time full depletion of the
-chains by ligating had not occurred (see Fig. 7 B).
Characteristic features of fibrin
network formation
Close examination of the fiber characteristics observed un-
der all the clotting conditions revealed definite patterns in
the manner in which normal fibrin assembles. Fiber densi-
ties were consistently1.56 times greater than their branch-
point densities (Fig. 8). Large fiber diameters and lengths
were established only when branching was minimal, and
increases in fiber lengths generally appeared to be accom-
panied by increases in fiber diameters (Fig. 9).
Fiber lengths and diameters decreased with increased
branching but did not further decrease above branchpoint
densities of 25 m3 (Fig. 8). Above this level, fibers
appeared to have reached their minimum sizes. Fiber
lengths plateaued to an average minimum length of 463 nm,
and fiber diameters decreased to an average minimum of 54
nm [10 monomers long and6–9 monomers thick, based
on the 45-nm length and 6–9-nm width of a fibrinogen
molecule measured by Hall and Slayter, 1959; Bachmann et
al., 1975; and Estis and Haschemeyer, 1980].
DISCUSSION
Determinants of clot structure
The kinetics of fibrin polymerization govern the structure of
a fibrin network (Hantgan and Hermans, 1979; Wolfe and
FIGURE 7 Reducing SDS-PAGE analysis of cross-linked chain profiles
at varying concentrations of calcium ion. Reaction mixtures (all containing
3 mg/ml fibrinogen) were clotted at 21°C for 2 h with EDTA (1 mM), lane
1; thrombin (1 NIHU/ml) and EDTA, lane 2; and thrombin and CaCl2
(0–20 mM) lanes 3–9. Samples included 1 mM (A) or 0 mM (B) FXIIIa
inhibitor.
FIGURE 6 Clotting time and rheological
behavior of clots formed with varying con-
centrations of calcium. Clots were formed at
21°C from solutions of fibrinogen (3 mg/ml),
thrombin (1 NIHU/ml), CaCl2 (0, 0.1, 0.2,
1.5, 5, 10, 20 mM), and 0 mM (solid sym-
bols) or 1 mM (open symbols) FXIIIa inhib-
itor. Clotting times and values of G, G, and
tan  were averaged from two sets of data;
error bars represent ranges of the data.
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Waugh, 1981; Blomback and Okada, 1982; Shah et al.,
1985; Carr et al., 1986; Weisel and Nagaswami, 1992). The
influence of the rates of polymerization on clot architecture
is clearly demonstrated in the modulation of fiber sizes by
varying concentrations of thrombin (Figs. 2 B and 3 B). The
observed effect of higher thrombin concentrations on di-
minishing fiber size is consistent with the results of perme-
ability experiments (Blomback et al., 1990), turbidity ex-
periments (Shah et al., 1985; Carr, 1988; and Blomback et
al., 1990), and electron microscopy (Weisel and Na-
gaswami, 1992). Lowering the concentration of the enzyme
reduces the rate of fibrinopeptide cleavage, resulting in a
slower production of fibrin monomers. Existing protofibrils
grow longer and aggregate laterally as monomers are slowly
produced, resulting in a network of long, thick fibers
(Weisel and Nagaswami, 1992). At higher thrombin con-
centrations, the rate of lateral and lengthwise fiber growth is
slow compared to the rate of fibrinopeptide cleavage. Thus,
several short oligomers are formed before they can join
lengthwise or associate laterally, resulting in a network of
thin, short fibers.
Similar effects of decreased fiber size are observed as
fibrinogen concentrations are increased (Figs. 2 A and 3 A).
Raising the concentration of fibrinogen might be expected
to lead to thicker fibers because of the decreased thrombin-
to-fibrinogen ratios (Weisel and Nagaswami, 1992), as re-
flected in the longer clotting times. However, the decreased
fiber diameters may be attributed to accelerated rates of
monomer formation because of higher substrate concentra-
tions. Similar decreases in fiber mass-to-length ratio were
observed in turbidity experiments on plasma clots by Carr
and Carr (1995), in permeability studies on fibrin clots by
Rosser et al. (1977), and in recent electron microscopy
experiments (Herbert et al., 1998). Other investigators,
however, reported increases (Shah et al., 1985) or no
changes (Blomback et al., 1990) in fiber mass-to-length
ratio with increases in fibrinogen. Further studies maintain-
ing constant ratios of thrombin to fibrinogen would be
useful in resolving the effects of fibrinogen concentration
on clot organization.
The increased fiber sizes in clots formed at elevated
calcium concentrations (Figs. 2 C and 3 C) are consistent
with the results of turbidity experiments by Okada and
Blomback (1983), Carr (1988), and Carr and Carr (1995).
Calcium has long been known to have an accelerating effect
on fibrin clotting (Rosenfeld and Janszky, 1952; Ratnoff
and Potts, 1954), due to the enhancement of one or more
polymerization events subsequent to fibrinopeptide cleav-
age (Lorand and Konishi, 1964; Boyer et al., 1972; Endres
and Scheraga, 1972; Brass et al., 1978; Blomback et al.,
1978; Hardy et al., 1983). Dang et al. (1989) suggested that
lateral aggregation is enhanced through decreases in charge
from the binding of calcium to sialic acid on the carbohy-
drates of fibrinogen. Increased calcium binding to fibrin
during polymerization also has been correlated with the
removal of fibrinopeptide B (Mihalyi, 1988). Calcium en-
hances the affinity of GHRP (the N-terminal tetrapeptide of
the fibrin -chain exposed after fibrinopeptide B release)
for fibrinogen (Laudano and Doolittle, 1981), thereby sta-
bilizing the protofibril and promoting its lengthwise growth
and lateral aggregation (Hantgan and Hermans, 1979; Hant-
gan et al., 1980, 1983; Fowler et al., 1981).
FIGURE 9 Dependence of fiber length on fiber diameter. Data were
obtained from the experiments in which fibrinogen concentration was
varied (Fig. 3 A, open triangles), thrombin concentration was varied (Fig.
3 B, open squares), and calcium ion concentration was varied (Fig. 3 C,
open circles, unligated; solid circles, ligated). Error bars represent standard
deviations of the data.
FIGURE 8 Effect of branchpoint density on fiber density, fiber length,
and fiber diameter. Data were obtained from the experiments in which
fibrinogen concentration was varied (Fig. 3 A, open triangles), thrombin
concentration was varied (Fig. 3 B, open squares), and calcium ion con-
centration was varied (Fig. 3 C, open circles, unligated; solid circles,
ligated). Error bars represent standard deviations of the data.
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The modulation of clot structure caused by changing the
rates of one or more steps of polymerization largely ex-
plains the characteristic networks observed in this investi-
gation. Under conditions that promote the formation of long
protofibrils, lateral aggregation is favored. Long fiber
lengths are, therefore, generally accompanied by large fiber
diameters (Fig. 9), as described by Baradet et al. (1995).
Branching becomes less frequent under conditions that pro-
mote lengthwise protofibril growth. The divergence of pro-
tofibrils from parent fibers may be inhibited by the in-
creased strength of binding acquired through the cumulation
of weak noncovalent interactions along the long protofi-
brils. Small branchpoint densities are, therefore, observed
in networks that have great fiber lengths and diameters
(Fig. 8).
A strong correlation between fiber density and branch-
point density was recognized in all the networks examined
(Fig. 8). The ratio of fiber density to branchpoint density
remained near 1.56 in every case (1.56 	 0.07), indicating
that an optimal degree of branching existed, regardless of
fiber size or the conditions under which the networks were
formed. During the construction of the computerized three-
dimensional fibrin network models, three or, occasionally,
four fibers were observed to join at a branchpoint. In rare
instances, more than four fibers at a branchpoint were seen.
These latter observations, however, were usually made at
locations at which the ability to distinguish the arrangement
of several coalescing fibers was limited by the resolution of
the micrographs. To characterize the branching observed in
the clots, the fiber-to-branchpoint ratios for models of “per-
fect” polymeric networks having constant degrees of
branching were calculated using the equation /  	/2
(Flory, 1953; Mark, 1982), in which  number of network
fibers,   number of network junctions, and 	  number
of chains meeting at each junction. Molecular theories de-
scribing polymeric networks define “perfect” networks to
be those that have no dangling fibers (fibers connected to a
junction of the network at only one end) or loops (fibers
having both ends attached to the same junction). Although
these types of networks do not occur in reality, the fibrin
clots examined displayed no loops and few fibers with
naturally occurring dangling ends. From the above equation,
a perfect network with three fibers joining at every junction
has a fiber-to-branchpoint ratio of 1.5. The ratio increases to
2 for networks in which four fibers join at each junction and
continues to rise as the degree of branching increases. Based
on these models, the experimentally determined fiber-to-
branchpoint ratio of 1.56 indicates that junctions at which
three fibers join are the dominant branchpoint type. In their
quantitative study of clot structure, Baradet et al. (1995)
also described a dominant number (three) of branchpoints at
every junction. Mosesson et al. (1993) described two types
of branching junctions in fibrin fibers formed in vitro, but
either type of junction would produce branchpoints at which
three fibers join.
Effects of network structure on clot rigidity
Pronounced increases in clot rigidity (G) were obtained as
fibrinogen concentrations were raised (Fig. 4). The in-
creased incidence of myocardial infarction in patients with
elevated levels of plasma fibrinogen has been attributed, in
part, to the less deformable clots formed at these concen-
trations (Scrutton et al., 1994), but the densely packed
structures observed at higher substrate levels may also con-
tribute to limited fibrinolysis. The small degree of change in
fiber diameters and lengths exhibited in this fibrinogen
range indicates that the most probable cause for the bol-
stered clot rigidity at higher substrate levels is not the
changes in fiber structure, but rather the increased density of
fibers resulting from the greater total mass of protein.
In contrast, modifications of fiber structure were most
likely responsible for the variances in rigidity observed in
clots formed with changing thrombin and calcium levels.
The peaking behavior of final clot rigidity with increasing
calcium concentration is consistent with the findings of
Shen et al. (1974, 1975); Marx (1988); Caprini et al. (1974);
and Carr and Carr (1995). The observed increase of final
clot stiffness between 0 and 0.25 NIHU/ml thrombin has
also been demonstrated by other investigators (Kaibara and
Fukada, 1971; Kaibara, 1973; Marx, 1988), but the detec-
tion of clot softening at higher levels of thrombin is unique
to this investigation. The observed clot softening is not
likely to be due to the digestion of fibrin by thrombin
(Triantaphyllopoulos and Chandra, 1973; Kang and Tri-
antaphyllopoulos, 1977a, b), as evidenced by the absence of
digested fibrin chain products in samples analyzed by re-
ducing SDS-PAGE after 2 h of clotting with 0 to 1
NIHU/ml thrombin (data not shown). Although a small
percentage of -chain digestion was detected at 5 NIHU/ml
thrombin, 68% of the decrease in clot rigidity had already
been established between 0.25 and 1 NIHU/ml. The fiber
lengths, diameters, and fiber and branchpoint densities that
generated maximum rigidities in the thrombin experiments
were strikingly similar to those producing peak stiffnesses
in the calcium experiments. The maximally stiff networks
of the thrombin and calcium experiments exhibited fiber
lengths of 2 and 1.3–1.4 m, fiber diameters of 83
and 75–90 nm, fiber densities of 9.3 and 8.4–9.1
m3, and branchpoint densities of 5 and 5.1 m3,
respectively.
Our results suggest that network stiffness is strongly
dependent on fiber thickness and branchpoint concentration.
The greater branching observed at high thrombin or low
calcium concentrations contributes to increased clot rigid-
ity; however, the reduction of fiber diameters accompany-
ing increased branching softens the network. Clots exhibit-
ing a balance between high branching density and large
fiber diameters, therefore, manifest the greatest stiffness.
This balance appears to occur in networks that display fiber
sizes and branchpoint densities that are intermediate.
Although clots exhibiting these intermediate fiber char-
acteristics are maximally rigid, their structures indicate that
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they may not necessarily be maximally resistant to fibrino-
lysis. Gabriel et al. (1992) and Carr and Alving (1995)
demonstrated that thinner fibers lyse at slower rates than
thicker ones, although Kolev et al. (1997) obtained conflict-
ing results. The softer clots formed with low calcium levels
or high thrombin levels may be less susceptible to fibrino-
lysis. The peak stiffnesses generated with physiological
levels of calcium (1.5–2 mM) may function to effectively
arrest bleeding, yet the intermediate fiber sizes and densities
established at these rigidities may give the clot the structure
necessary for maintaining a proper balance between coag-
ulation and fibrinolysis. Although normal plasma levels of
prothrombin have been determined, 1 to 2 M (Fenton et
al., 1977) plasma concentrations of thrombin are suspected
to vary considerably (Blomback et al., 1984), particularly at
sites of lesions. The physiological significance of maximum
rigidities developing with 0.25 NIHU/ml thrombin is, there-
fore, difficult to ascertain.
Effects of network structure on energy
dissipation during clot deformation
On a molecular basis, the dissipation of energy reflected by
the loss modulus is believed to originate from molecular or
atomic adjustments (Ferry, 1970). In a clot, these adjust-
ments may arise from the dissociation of non-covalently
linked adjacent fibrin monomers and the slippage of proto-
fibrils or fibers between one another. In all of the experi-
ments performed, the concentration dependence of G at 2 h
closely mimicked that of G at 2 h. A parameter that
revealed more information about network structural rear-
rangements than G was the loss tangent, which reflects the
ratio of energy dissipated to energy stored in a sample
during deformation.
The network feature that showed the greatest effect on the
loss tangent was fiber diameter. In all of the cases exam-
ined, smaller values of tan  were produced in networks
displaying smaller fiber diameters (Fig. 10), indicating that
structural rearrangements between fibers or protofibrils
were less common in clots having thinner fibers. The greater
degree of branching observed in networks with thin fibers
(see Fig. 8) may point to the importance of branching in
inhibiting configurational rearrangements that result in the
loss of elastic energy. At all fiber diameters, values of tan 
and G for the ligated networks were smaller than those of
the unligated clots (Figs. 6 and 10). The presence of cova-
lent linkages between the assembled fibrin monomers is
believed to secure protofibrils together and prevent disso-
ciations between adjacent molecules, resulting in reinforced
networks that dissipate diminished levels of energy during
deformation.
Effects of cross-linking on network structure
At all the calcium ion concentrations examined, the pres-
ence of ligations was shown to slightly decrease network
fiber diameters, causing concomitant increases in their
lengths (Fig. 3 C). This effect was observed even at 0.2 mM
CaCl2, at which -chain ligating is complete by 2 h and
-chain ligating is just beginning (Fig. 7). The structural
changes are not greatly enhanced as -chain ligating is
promoted at higher CaCl2 concentrations, indicating that the
altered fiber lengths and diameters may be caused by the
formation of -chain cross-links alone.
The changes in fiber structure generated by ligating are
small, relative to the entire range of structural changes
observed in this investigation; qualitative differences be-
tween the morphology of the unligated and ligated networks
are difficult to detect visually without the aid of direct
measurements. Muller et al. (1984) reported no changes in
the general appearance under electron microscopy of fibrin
networks stabilized by FXIIIa, and the mass-length ratios of
fibers examined in turbidity experiments (Carr et al., 1987)
were not affected by FXIIIa-induced stabilization, although
fiber densities did increase. The changes in fiber length and
diameter brought about by ligating are most likely too small
to solely account for the 2- to 4-fold augmentation of
rigidity observed upon the introduction of ligations. Only
minimal differences in fiber and branchpoint densities were
detected between clots formed with and without FXIIIa
inhibitor, indicating that the FXIIIa-induced enhancement
of clot rigidity does not originate from alterations in net-
work morphology (i.e., the formation of new branchpoints
or increased lateral aggregation), but most likely from the
stiffening of the individual fibers already existing. The
tightening of lateral bonds between the fibrin monomers in
a fiber brought about by the ligations could account for the
slight decrease in fiber diameter, stiffening of the fibers, and
the large increase in clot stiffness.
Evidence exists to suggest that the degree of stiffening
produced by ligating may be dependent on network struc-
ture. The rigidity of a network having thick, long fibers and
little branching is augmented 2.4 times when ligated in the
FIGURE 10 Dependence of loss tangent on fiber diameter. Data were
obtained from the experiments in which fibrinogen concentration was
varied (Fig. 3 A, open triangles), thrombin concentration was varied (Fig.
3 B, open squares), and calcium ion concentration was varied (Fig. 3 C,
open circles, unligated; solid circles, ligated). Error bars represent standard
deviations of the data.
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presence of 20 mM CaCl2 (Fig. 6). At this calcium concen-
tration, ligating causes a complete depletion of the -chains
(Fig. 7). A network with reduced fiber diameters but greater
branching, however, requires a smaller percentage (68%) of
the -chains to be ligated for a greater (3.7-fold) enhance-
ment of stiffness to be produced (at 1.5 mM CaCl2). These
results indicate that the augmentation of rigidity by ligating
may be favored in networks that exhibit specific morpho-
logical features. For example, Mosesson et al. (1989) pos-
tulated that -trimers and -tetramers arise specifically at
fibril branchpoints or at sites of lateral fiber association. In
addition, -chain ligation has been shown to be favored
under fine clotting conditions, whereas both - and -chain
ligations form under coarse conditions (Gerth et al., 1974).
Elucidating the configuration of the various ligated species
within the fibrin networks would be critical for determining
their rheological effects on networks of varying structure.
The possibility of regulating cross-link formation through
the manipulation of network architecture remains to be
explored.
CONCLUSIONS
The results of these experiments show that clot rheological
behavior is regulated by at least the following three factors.
Fibrinogen concentration: Increased fibrinogen concentra-
tions elevate clot rigidities through the establishment of
greater fiber and branchpoint densities. Fibrin network ar-
chitecture: Fibrin polymerizes in a characteristic manner,
allowing fibers to grow to sizable lengths and diameters
only when branching is minimal. Maximal stiffnesses are
manifested in clots that display fiber lengths, diameters,
densities, and branchpoint densities that are intermediate in
magnitude within the ranges observed. The high rigidities
exhibited by clots that display this type of network mor-
phology appear to result from a balance between a high
degree of branching and thicker fibers, characteristics that
both enhance network rigidity but are antithetical, since
more branching leads to thinner fibers and thicker fibers
yield less branching. Rearrangements in clot structure that
lead to losses of elastic energy during deformation appear to
be more common in clots having thicker fibers. FXIIIa-
induced ligation: Ligating produces slight decreases in fiber
diameter and increases in fiber length, but does not alter
lateral aggregation or branching. Ligating appears to en-
hance clot rigidity and decrease clot loss modulus by sta-
bilizing the interactions between preassembled protofibrils,
thereby increasing fiber flexural stiffness. The degree to
which the presence of ligations augments network rigidity
appears to be dependent on the structure of the fibers
stiffened.
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